Trial · NCT03651895
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| First Drug Assignment | STARTED | Metformin First (Before Crossover), Placebo Second (After Crossover) | 7 | |
| First Drug Assignment | STARTED | Placebo First (Before Crossover), Metformin Second (After Crossover) | 7 | |
| First Drug Assignment | 1 Month | Metformin First (Before Crossover), Placebo Second (After Crossover) | 6 | |
| First Drug Assignment | 1 Month | Placebo First (Before Crossover), Metformin Second (After Crossover) | 6 | |
| First Drug Assignment | 3 Months | Metformin First (Before Crossover), Placebo Second (After Crossover) | 3 | |
| First Drug Assignment | 3 Months | Placebo First (Before Crossover), Metformin Second (After Crossover) | 2 | |
| First Drug Assignment | COMPLETED | Metformin First (Before Crossover), Placebo Second (After Crossover) | 3 | |
| First Drug Assignment | COMPLETED | Placebo First (Before Crossover), Metformin Second (After Crossover) | 2 | |
| First Drug Assignment | NOT COMPLETED | Metformin First (Before Crossover), Placebo Second (After Crossover) | 4 | |
| First Drug Assignment | NOT COMPLETED | Placebo First (Before Crossover), Metformin Second (After Crossover) | 5 | |
| Second Drug Assignment - Crossover | STARTED | Metformin First (Before Crossover), Placebo Second (After Crossover) | 2 | |
| Second Drug Assignment - Crossover | STARTED | Placebo First (Before Crossover), Metformin Second (After Crossover) | 3 | |
| Second Drug Assignment - Crossover | 1 Month | Metformin First (Before Crossover), Placebo Second (After Crossover) | 2 | |
| Second Drug Assignment - Crossover | 1 Month | Placebo First (Before Crossover), Metformin Second (After Crossover) | 2 | |
| Second Drug Assignment - Crossover | COMPLETED | Metformin First (Before Crossover), Placebo Second (After Crossover) | 1 | |
| Second Drug Assignment - Crossover | COMPLETED | Placebo First (Before Crossover), Metformin Second (After Crossover) | 2 | |
| Second Drug Assignment - Crossover | NOT COMPLETED | Metformin First (Before Crossover), Placebo Second (After Crossover) | 1 | |
| Second Drug Assignment - Crossover | NOT COMPLETED | Placebo First (Before Crossover), Metformin Second (After Crossover) | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03651895/flow